MGCD-265 analog

CAS No.	875337-44-3	Cat. No.	BCP02390
Name	MGCD-265 analog
Synonyms	MGCD 265 analog; MGCD265 analog;Glesatinib analog;
Formula	C26H20FN5O2S2	M. Wt	517.61

Description	MGCD265-analog is structurally related to MGCD-265 (Glesatinib). MGCD-265-analog is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity. MGCD-265-analog was introduced to the research community due to the wrong structure published in some database and publications. MGCD-265-analog has been sold as MGCD-265 by many reagent vendors since 2012. As of 4/28/2016, many drug-related database and suppliers still listed a wrong structure for MGCD-265. MGCD-265 (Glesatinib) has CAS#936694-12-1.
Pathways	Angiogenesis/Protein Tyrosine Kinase
Targets	c Met VEGFR Tie2

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.